Kimberly-Clark Corporation reported fourth-quarter and full-year financial results Tuesday, showing a rise in sales and profits as the company moves forward with its new facility in Warren.

The company, which makes brands like Huggies and Kleenex, earned $4.1 billion in sales during the final three months of 2025. This growth occurred even as the company stopped making certain store-brand diapers in the United States. For the full year, the company reported $16.4 billion in sales. Executives said the results show that their plan to focus on personal care products is working.

"We delivered results that show the strength of our business," said Mike Hsu, the company's chairman and CEO. He noted that the company is currently going through the largest change in its 150-year history. The report comes as the company continues to build an $800 million facility in Warren. Local officials previously stated the project would create nearly 500 jobs for the Mahoning Valley and would be one of the largest Kimberly-Clark sites in the world.

In the fourth quarter, the company made $507 million in operating profit, which was an increase from the previous year. Kimberly-Clark also gave $1.8 billion back to its investors through dividends and by buying back its own stock.

Additionally, the company is in the process of buying Kenvue to help expand its reach to more people around the world. Kenvue is a consumer health company that was formerly a division of Johnson & Johnson and owns well-known brands such as Tylenol, Band-Aid, and Listerine.

Looking ahead to 2026, the company expects its sales to continue growing. Leaders said they will keep focusing on saving money while investing in their most popular brands. Construction on the Warren plant is expected to finish within the next three years. Once open, it will produce many of the personal care items that contributed to the company's recent financial gains.